![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 38, 34846-34852, September 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Clostridial neurotoxins potently and specifically
inhibit neurotransmitter release in defined cell types. Here we report
that a catalytically active derivative (termed LHN/A)
of the type A neurotoxin from Clostridium botulinum has
been coupled to a lectin obtained from Erythrina
cristagalli to form a novel conjugate. This conjugate exhibits an
in vitro selectivity for nociceptive afferents compared
with the anatomically adjacent spinal neurons, as assessed using
in vitro primary neuronal culture systems to measure
inhibition of release of neurotransmitters. Chemical conjugates prepared between E. cristagalli lectin and either natively
sourced LHN/A or recombinant LHN/A purified
from Escherichia coli are assessed, and equivalence of the
recombinant material are demonstrated. Furthermore, the dependence of
inhibition of neurotransmitter release on the cleavage of SNAP-25 is
demonstrated through the use of an endopeptidase-deficient
LHN/A conjugate variant. The duration of action of
inhibition of neurotransmitter released by the conjugate in
vitro is assessed and is comparable with that observed with
Clostridium botulinum neurotoxin. Finally, in
vivo electrophysiology shows that these in vitro
actions have biological relevance in that sensory transmission from
nociceptive afferents through the spinal cord is significantly
attenuated. These data demonstrate that the potent endopeptidase
activity of clostridial neurotoxins can be selectively retargeted to
cells of interest and that inhibition of release of neurotransmitters
from a neuronal population of therapeutic relevance to the treatment of
pain can be achieved.
Inhibition of Release of Neurotransmitters from Rat Dorsal Root
Ganglia by a Novel Conjugate of a Clostridium botulinum
Toxin A Endopeptidase Fragment and Erythrina cristagalli
Lectin*
§,
¶,
,
,
,
,
,
,
,
,
,
,
, and
Centre for Applied Microbiology and
Research, Porton Down, Salisbury, Wiltshire SP4 0JG, United Kingdom and
the ** University College London, University College, Gower
Street, London WC1E 6BT, United Kingdom
*
This work was supported by Allergan Inc.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
44-0-1980-612733; Fax: 44-0-1980-611310; E-mail:
john.chaddock@camr.org.uk.
This article has been cited by other articles:
![]() |
K. Turton, R. Natesh, N. Thiyagarajan, J. A. Chaddock, and K. R. Acharya Crystal structures of Erythrina cristagalli lectin with bound N-linked oligosaccharide and lactose Glycobiology, October 1, 2004; 14(10): 923 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
V P. Misra The changed image of botulinum toxin BMJ, November 23, 2002; 325(7374): 1188 - 1188. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |